Evidence map›Paper›PMID 31723020›Full record

ArticleJournal of virology2020

LANA and hnRNP A1 Regulate the Translation of LANA mRNA through G-Quadruplexes.

Prerna Dabral, Jay Babu, Andrew Zareie, Subhash C Verma

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 43 citations in OpenAlex.

  1. Increasing intrinsic protein disorder improves CD8+ immunogenicity for a SARS CoV2 vaccine candidate antigen.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. From development to disease: the neuronal role of hnRNPs through the lens ofFrontiers in cell and developmental biology · 2026
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Anti-nucleolin aptamer AS1411: an advancing therapeutic.Frontiers in molecular biosciences · 2023
    Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Prerna DabralDepartment of Microbiology and Immunology, Reno School of Medicine, University of Nevada, Reno, Nevada, USA.
Jay BabuDepartment of Microbiology and Immunology, Reno School of Medicine, University of Nevada, Reno, Nevada, USA.
Andrew ZareieDepartment of Microbiology and Immunology, Reno School of Medicine, University of Nevada, Reno, Nevada, USA.
Subhash C VermaDepartment of Microbiology and Immunology, Reno School of Medicine, University of Nevada, Reno, Nevada, USA scverma@medicine.nevada.edu.ORCID 0000-0002-0492-6578
University of Nevada, Reno · US

Funding

KSHV Lytic DNA Replication and its Control MechanismR01AI105000 · NIAID · UNIVERSITY OF NEVADA RENO · PI VERMA, SUBHASH C · 2013 to 2017
$1.8M
KSHV Genome Replication during Primary InfectionR01CA174459 · NCI · UNIVERSITY OF NEVADA RENO · PI VERMA, SUBHASH C · 2013 to 2017
$1.5M
NCI NIH HHS R01 CA174459NIAID NIH HHS R01 AI105000
6 · The paper itself

Abstract

During the latent phase, Kaposi's sarcoma-associated herpes virus (KSHV) maintains itself inside the host by escaping the host immune surveillance mechanism through restricted protein expression. Latency-associated nuclear antigen (LANA), the most abundantly expressed protein, is essential for viral persistence, as it plays important roles in latent viral DNA replication and efficient segregation of the viral genome to the daughter cells following cell division. KSHV evades immune detection by maintaining the levels of LANA protein below a threshold required for detection by the host immune system but sufficient to maintain the viral genome. LANA achieves this by controlling its expression through regulation of its promoters and by inhibiting its presentation through interaction with the proteins of class I and class II major histocompatibility complex (MHC) pathways. In this study, we identified a mechanism of LANA expression and restricted immune recognition through formation of G-quadruplexes in LANA mRNA. We show that the formation of these stable structures in LANA mRNA inhibits its translation to control antigen presentation, which was supported by treatment of cells with TMPyP4, a G-quadruplex-stabilizing ligand. We identified heterogenous ribonucleoprotein A1 (hnRNP A1) as a G-quadruplex-unwinding helicase, which unfolds these stable secondary structures to regulate LANA translation.

Indexed as

G-QuadruplexesAntigens, ViralBase SequenceCell LineDNA, ViralGenome, ViralHerpesvirus 8, HumanHeterogeneous Nuclear Ribonucleoprotein A1HumansMajor Histocompatibility ComplexNuclear ProteinsRNA, MessengerVirus LatencyVirus ReplicationAntigens, ViralDNA, ViralHeterogeneous Nuclear Ribonucleoprotein A1latency-associated nuclear antigenNuclear ProteinsRNA, MessengerG-quadruplexhRNP A1KSHVLANAlatency

Identifiers

PMID31723020
PMCPMC7000962
OpenAlexW2985201151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.